Tybourne Capital Management »

Forte Biosciences shares owned by Tybourne Capital Management

Quarter-by-quarter ownership of Forte Biosciences (FBRX) shares owned by Tybourne Capital Management from 13F filings

Historical chart of Tybourne Capital Management investment in Forte Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Forte Biosciences held by Tybourne Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Forte Biosciences by Tybourne Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $810k 145k 5.59

More positions owned by Tybourne Capital Management

Texas Instruments Incorporated (TXN)
Canadian Pacific Kansas City (CP)
Lpl Financial Holdings (LPLA)
Epam Systems (EPAM)
Iqvia Holdings (IQV)
Bicycle Therapeutics Ltd- Sponsored Ads (BCYC)
Amazon (AMZN)
S&p Global (SPGI)
Acelyrin (SLRN)
Linde SHS (LIN)
Taysha Gene Therapies Com Shs (TSHA)
Seagate Technology Holdings Ord Shs (STX)
Taiwan Semiconductor-sp Sponsored Ads (TSM)
Zentalis Pharmaceuticals (ZNTL)
Cargurus Com Cl A (CARG)

View all positions for Tybourne Capital Management

Top funds holding Forte Biosciences

Tybourne Capital Management
BVF
Perceptive Advisors
Fred Alger Management
Cable Car Capital
Farallon Capital Management
BML Capital Management
Vanguard Group
Geode Capital Management
Susquehanna International
BlackRock
ADAR1 Capital Management
UBS Group
Tower Research Capital
Group One Trading

View all funds holding Forte Biosciences